P2OD34 logo

Insulet BOVESPA:P2OD34 Stock Report

Last Price

R$54.00

Market Cap

R$114.4b

7D

0%

1Y

n/a

Updated

24 Dec, 2024

Data

Company Financials +

Insulet Corporation

BOVESPA:P2OD34 Stock Report

Market Cap: R$114.4b

P2OD34 Stock Overview

Develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. More details

P2OD34 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance5/6
Financial Health5/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Insulet Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Insulet
Historical stock prices
Current Share PriceUS$54.00
52 Week HighUS$54.00
52 Week LowUS$27.91
Beta1.22
1 Month Change3.75%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO24.55%

Recent News & Updates

Recent updates

Shareholder Returns

P2OD34BR Medical EquipmentBR Market
7D0%-0.4%-0.8%
1Yn/a7.7%-13.7%

Return vs Industry: Insufficient data to determine how P2OD34 performed against the BR Medical Equipment industry.

Return vs Market: Insufficient data to determine how P2OD34 performed against the BR Market.

Price Volatility

Is P2OD34's price volatile compared to industry and market?
P2OD34 volatility
P2OD34 Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.1%
Market Average Movement5.0%
10% most volatile stocks in BR Market9.6%
10% least volatile stocks in BR Market2.9%

Stable Share Price: P2OD34's share price has been volatile over the past 3 months compared to the BR market.

Volatility Over Time: Insufficient data to determine P2OD34's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
20003,000Jim Hollingsheadwww.insulet.com

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company’s Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally.

Insulet Corporation Fundamentals Summary

How do Insulet's earnings and revenue compare to its market cap?
P2OD34 fundamental statistics
Market capR$114.41b
Earnings (TTM)R$2.61b
Revenue (TTM)R$12.29b

43.9x

P/E Ratio

9.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
P2OD34 income statement (TTM)
RevenueUS$1.98b
Cost of RevenueUS$595.20m
Gross ProfitUS$1.39b
Other ExpensesUS$967.80m
EarningsUS$420.90m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)6.00
Gross Margin70.00%
Net Profit Margin21.22%
Debt/Equity Ratio123.4%

How did P2OD34 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 07:35
End of Day Share Price 2024/12/16 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Insulet Corporation is covered by 58 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anand VankawalaAvondale Partners
Jeffrey JohnsonBaird
null nullBaird